← All stocks

PLIANT THERAPEUTICS, INC.

PLRX Net selling

CIK 0001746473 #4543 in the set updated 22 Sep 2026

Bought (120 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$25.42M

$8.23M on a plan · $11.35M straight out of an exercise

Sold at will

$5.83M

31 of 103 sales

Net

−$25.42M

−$5.83M against sales at will

By person

12 insiders · 116 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Coulie Bernard

President and CEO

—

$13.58M (51) scheduled

−$13.58M

1,364,235

2.20%

$1.75M

+50.4%

Lefebvre Eric

Chief Medical Officer

—

$5.13M (16)

−$5.13M

240,224

0.3879%

$307.49K

+32.2%

Cummings Keith Lamont

Chief Financial Officer

—

$2.97M (12) scheduled

−$2.97M

297,214

0.4800%

$380.43K

+3,839%

Hull Hans

Chief Business Officer

—

$1.89M (9) scheduled

−$1.89M

265,693

0.4291%

$340.09K

+111.6%

Ouimette Mike

General Counsel & Corp. Sec'y

—

$1.79M (12) scheduled

−$1.79M

105,544

0.1704%

$135.10K

—

Cheung Lily

Chief Human Resource Officer

—

$51.54K (2) scheduled

−$51.54K

44,847

0.0724%

$57.40K

+956.2%

Kuo Minnie

Chief Operating Officer

—

$8.85K (1) scheduled

−$8.85K

37,806

0.0611%

$48.39K

−15.5%

Third Rock Ventures III, L.P. entity

10% owner

—

3,972,027

6.41%

$5.08M

+1,320%

Redmile Group, LLC entity

10% owner

—

1,910,657

3.09%

$2.45M

—

Huh Hoyoung

Director

—

239,619

0.3870%

$306.71K

+140.2%

Howes Barbara

Chief Human Resource Officer

—

24,799

0.0400%

$31.74K

+18.2%

Exter Neil

Director

—

0.0000%

$0.00

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 188

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 4

Sales on a Rule 10b5-1 plan 34

Sales straight out of an exercise 38

Sales at will 31

Transactions with no price 0

Shares from compensation/vesting 16,043,681

Sales filed before the plan box existed 31

History held since 9 Jun 2020